Li Yuntong, Xia Yong, Li Jun, Wu Dong, Wan Xuying, Wang Kui, Wu Mengchao, Liu Jingfeng, Lau Wan Yee, Shen Feng
Department of Hepatobiliary Surgery, the Mengchao Hepatobiliary Surgery Hospital, Fujian Medical University, Fuzhou, China; Department of Hepatic Surgery, the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Department of Hepatic Surgery, the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
J Am Coll Surg. 2015 Nov;221(5):962-974.e4. doi: 10.1016/j.jamcollsurg.2015.08.003. Epub 2015 Aug 10.
Liver resection is an effective treatment in select patients with huge hepatocellular carcinoma (HCC, diameter ≥10 cm). This study aimed to develop nomograms for pre- and postoperative predictions of overall survival (OS) for these patients.
There were 464 consecutive patients who underwent liver resection for huge HCC at the Eastern Hepatobiliary Surgery Hospital (EHBH) between January 2008 and December 2009. They were collected and divided into a training cohort (n = 310) and an internal validation cohort (n = 154). Another 90 patients who were operated on at the Fujian Medical University (FMU) between January 2008 and April 2010 served as an external validation cohort. The surgical morbidity, mortality, time to recurrence, and OS were observed. Two prognostic nomograms were developed based separately on the data obtained before and after surgery. Discrimination and predictive accuracy of the models were measured using concordance index (C-index), calibration curves, and validation study.
The postoperative 4-year tumor recurrence and OS rates were, respectively, 79.0% and 41.2% in the patients from the EHBH and 78.8% and 37.6% in those from the FMU. Independent predictors of OS on multivariable analysis using pre- and postoperative data were respectively incorporated into the 2 nomograms. In the training cohort, calibration curves for the probability of 4-year postoperative survival fitted well. The C-indexes of the pre- and postoperative nomograms in predicting OS were 0.75 (95% CI 0.72 to 0.78) and 0.78 (95% CI 0.75 to 0.81), respectively. The internal and external validation studies optimally supported these results.
The 2 nomograms achieved accurate pre- or postoperative predictions of long-term survival for patients with huge HCC after liver resection.
肝切除术是治疗部分巨大肝细胞癌(HCC,直径≥10 cm)患者的有效方法。本研究旨在建立用于术前和术后预测这些患者总生存期(OS)的列线图。
2008年1月至2009年12月期间,在东方肝胆外科医院(EHBH)连续有464例接受肝切除术治疗巨大HCC的患者。将他们收集起来并分为训练队列(n = 310)和内部验证队列(n = 154)。另外90例于2008年1月至2010年4月在福建医科大学(FMU)接受手术的患者作为外部验证队列。观察手术并发症、死亡率、复发时间和总生存期。分别根据术前和术后获得的数据建立了两个预后列线图。使用一致性指数(C指数)、校准曲线和验证研究来衡量模型的辨别力和预测准确性。
EHBH患者术后4年肿瘤复发率和总生存率分别为79.0%和41.2%,FMU患者分别为78.8%和37.6%。使用术前和术后数据进行多变量分析时,总生存期的独立预测因素分别纳入两个列线图。在训练队列中,术后4年生存概率的校准曲线拟合良好。术前和术后列线图预测总生存期的C指数分别为0.75(95%CI 0.72至0.78)和0.78(95%CI 0.75至0.81)。内部和外部验证研究均最佳地支持了这些结果。
这两个列线图实现了对肝切除术后巨大HCC患者长期生存的准确术前或术后预测。